Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis
- PMID: 21091667
- PMCID: PMC3043305
- DOI: 10.1111/j.1365-2249.2010.04288.x
Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis
Abstract
Autoantibodies to intracellular targets in mitochondria and nuclei are serological hallmarks of primary biliary cirrhosis (PBC). One of the most recently identified cellular targets of PBC autoantibodies is a novel cytoplasmic structure referred to as GW bodies [GWB, G (glycine) W (tryptophan)-containing bodies (GWB)]. GWB are indentified as discrete cytoplasmic domains that are involved in mRNA processing via the RNA interference (RNAi) pathway. Key components of GWB include the proteins GW182, Ago2, RNA-associated protein 55 (RAP55) and Ge-1/Hedls. The primary objective was to study the frequency and clinical association of antibodies directed to GWB components, in 109 PBC patients. Autoantibodies to mitochondrial antigen-pyruvate dehydrogenase complex (M2), branched-chain 2-oxo-acid dehydrogenase complex and 2-oxo glutarate dehydrogenase complex (3E-BPO), gp210, sp100, promyelocytic leukaemia cell antigen (PML) and liver kidney microsomal-1 antigen (LKM-1) were detected by a line immunoassay and antibodies to GWB (GW182, RAP55, Ge-1, GW2, GW3) and glutamate receptor interacting protein (GRIP)-associated protein-1 (GRASP-1), by an addressable laser bead immunoassay (ALBIA). The most common GWB autoantigen targets were: RAP55-28%, GW182-12%, GW2-2% and antibodies to GRASP-1-17%. By comparison, the frequency of reactivity to established PBC autoantigens was: gp210, 27%; sp100, 27% and PML, 17%. None of the autoantibodies were associated with differences in Mayo risk score or liver decompensation. This study is the first study to show that antibodies to RAP55, GW182 and GRASP-1 are the most common GWB targets in PBC.
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.
Figures
Similar articles
-
Clinical and serological features of patients with autoantibodies to GW/P bodies.Clin Immunol. 2007 Dec;125(3):247-56. doi: 10.1016/j.clim.2007.07.016. Epub 2007 Sep 17. Clin Immunol. 2007. PMID: 17870671 Free PMC article.
-
[Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Apr 18;44(2):209-14. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22516989 Chinese.
-
Autoantibodies to mRNA processing pathways (glycine and tryptophan-rich bodies antibodies): prevalence and clinical utility in a South Australian cohort.Pathology. 2019 Dec;51(7):723-726. doi: 10.1016/j.pathol.2019.07.008. Epub 2019 Oct 17. Pathology. 2019. PMID: 31630877
-
Autoantibodies against "nuclear dots" in primary biliary cirrhosis.Semin Liver Dis. 1997 Feb;17(1):71-8. doi: 10.1055/s-2007-1007184. Semin Liver Dis. 1997. PMID: 9089912 Review.
-
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis.Expert Rev Mol Diagn. 2012 Jan;12(1):65-74. doi: 10.1586/erm.11.82. Expert Rev Mol Diagn. 2012. PMID: 22133120 Review.
Cited by
-
An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.Medicine (Baltimore). 2014 Nov;93(24):383-394. doi: 10.1097/MD.0000000000000223. Medicine (Baltimore). 2014. PMID: 25500708 Free PMC article.
-
Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.Mol Cell Proteomics. 2012 Sep;11(9):669-80. doi: 10.1074/mcp.M111.015529. Epub 2012 May 30. Mol Cell Proteomics. 2012. PMID: 22647870 Free PMC article.
-
A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes.Front Mol Med. 2022 Jul 8;2:914505. doi: 10.3389/fmmed.2022.914505. eCollection 2022. Front Mol Med. 2022. PMID: 39086971 Free PMC article. Review.
-
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.Gastroenterology. 2021 Jun;160(7):2483-2495.e26. doi: 10.1053/j.gastro.2021.02.061. Epub 2021 Mar 4. Gastroenterology. 2021. PMID: 33675743 Free PMC article.
-
Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).PLoS One. 2018 Mar 19;13(3):e0193960. doi: 10.1371/journal.pone.0193960. eCollection 2018. PLoS One. 2018. PMID: 29554146 Free PMC article.
References
-
- Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50:291–308. - PubMed
-
- Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005–13. - PubMed
-
- Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis. 2008;12:261–76. - PubMed
-
- Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev. 2003;2:211–17. - PubMed
-
- Bloch DB, Yu JH, Yang WH, et al. The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis. J Rheumatol. 2005;32:477–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials